Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins

  • Quan D. Zhou
  • , Xun Chi
  • , Min Sub Lee
  • , Wei Yuan Hsieh
  • , Jonathan J. Mkrtchyan
  • , An Chieh Feng
  • , Cuiwen He
  • , Autumn G. York
  • , Viet L. Bui
  • , Eliza B. Kronenberger
  • , Alessandra Ferrari
  • , Xu Xiao
  • , Allison E. Daly
  • , Elizabeth J. Tarling
  • , Robert Damoiseaux
  • , Philip O. Scumpia
  • , Stephen T. Smale
  • , Kevin J. Williams
  • , Peter Tontonoz
  • , Steven J. Bensinger

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Abstract

Plasma membranes of animal cells are enriched for cholesterol. Cholesterol-dependent cytolysins (CDCs) are pore-forming toxins secreted by bacteria that target membrane cholesterol for their effector function. Phagocytes are essential for clearance of CDC-producing bacteria; however, the mechanisms by which these cells evade the deleterious effects of CDCs are largely unknown. Here, we report that interferon (IFN) signals convey resistance to CDC-induced pores on macrophages and neutrophils. We traced IFN-mediated resistance to CDCs to the rapid modulation of a specific pool of cholesterol in the plasma membrane of macrophages without changes to total cholesterol levels. Resistance to CDC-induced pore formation requires the production of the oxysterol 25-hydroxycholesterol (25HC), inhibition of cholesterol synthesis and redistribution of cholesterol to an esterified cholesterol pool. Accordingly, blocking the ability of IFN to reprogram cholesterol metabolism abrogates cellular protection and renders mice more susceptible to CDC-induced tissue damage. These studies illuminate targeted regulation of membrane cholesterol content as a host defense strategy.

Original languageEnglish
Pages (from-to)746-755
Number of pages10
JournalNature Immunology
Volume21
Issue number7
DOIs
StatePublished - Jul 1 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.

Funding

This research was supported by NIH grants AI093768 (to S.J.B.), HL146358 (to S.J.B. and P.T.), AR073940 (to P.O.S), and HL136543 (to E.J.T.). M.S.L. is supported by Ruth L. Kirschstein National Research Service Award AI007323. The research described was also supported by an NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI grant (UL1TR001881). We thank S. Young, T. Weston and R.S. Jung for help with protein purification. We thank T. Weston for NanoSIMS sample preparation and SEM imaging. We thank A. Divakaruni for guidance with PFO permeabilization assays. We thank A. Radhakrishnan for ALO-D4 and full-length ALO plasmids. We thank S. Young, A. Hoffmann, Y. Du, R. Sun, T.-T. Wu, J. F. Miller and M. Li for thoughtful discussions.

FundersFunder number
NIH National Center for Advancing Translational Sciences and Center for Clinical and Translational Science
UCLA CTSI
National Institutes of Health (NIH)AR073940
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute Family Blood Pressure ProgramR01HL136543, HL146358
National Heart, Lung, and Blood Institute Family Blood Pressure Program
National Center for Advancing Translational Sciences (NCATS)UL1TR001881
National Center for Advancing Translational Sciences (NCATS)
Division of Intramural Research, National Institute of Allergy and Infectious DiseasesAI093768, AI007323
Division of Intramural Research, National Institute of Allergy and Infectious Diseases

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Fingerprint

    Dive into the research topics of 'Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins'. Together they form a unique fingerprint.

    Cite this